Dr. Edward D. Agura, MD
- Medicare services, 2019
- 1,342
- Part D claims, 2019
- 228
- Publications
- 44
- Clinical trials
- 10
- Industry payments
- $6,339
- Practice address
- 20870 Mack Ave, Grosse Pointe Woods, MI 48236
- Practice phone
- Call (313) 885-2334
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Center for Preventive Medicine
Grosse Pointe Woods, Michigan
Find Dr. Agura's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Edward D. Agura is a hematologist and oncologist in Grosse Pointe Woods, Michigan
Dr. Agura practices at Center for Preventive Medicine in Grosse Pointe Woods, Michigan.
Dr. Agura's NPI, 1871531350, was assigned on June 4, 2006. Dr. Agura graduated from New York University School of Medicine in 1982. Dr. Agura's Texas license number on file is J5681.
- NPI
- 1871531350NPI Registry (opens in a new tab)
- NPI enumeration date
- June 4, 2006
- NPI status
- Active
- Practice phone
- (313) 885-2334
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1982
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Edward D. Agura practices at Center for Preventive Medicine in Grosse Pointe Woods, Michigan
Dr. Agura's primary practice is Center for Preventive Medicine, at 20870 Mack Ave, Grosse Pointe Woods, MI 48236 in Wayne County. The practice phone is (313) 885-2334.
- Center for Preventive Medicine20870 Mack Ave, Grosse Pointe Woods, MI 48236 · Wayne CountyPhone(313) 885-2334
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Edward D. Agura is affiliated with 1 site of care
Dr. Agura's primary practice is Center for Preventive Medicine in Grosse Pointe Woods, Michigan.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Edward D. Agura's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agura practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Center for Preventive Medicine | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Edward D. Agura is one of 298 hematologists and oncologists in Michigan
Hematology and oncology is Dr. Agura's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Agura has a license on file in Texas.
Specialties and state licenses
- Hematology and oncology, TexasPrimary
Hematologists and oncologists near Dr. Agura
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Edward D. Agura billed Medicare for 1,342 services in 2019
CMS data shows 1,342 Medicare services from Dr. Agura across 15 procedure codes in 2019. Medicare paid $44,379 for them.
Dr. Agura's Medicare services by type, 2018 to 2019
- 2018
- 2019
- Lab and pathology
- 2018: 1,5532019: 79449%
- Office and hospital visits
- 2018: 6152019: 33146%
- Tests and treatments
- 2018: 2782019: 13751%
- Surgery
- 2018: 2522019: 8068%
- Drugs given in the office
- 2018: 302019: 0100%
- Other services
- 2018: 23,2942019: 0100%
Where Dr. Agura's Medicare services took place, 2019
- In an office1,15586%
- In a facility18714%
Dr. Agura compared with the Michigan median for hematologists and oncologists, 2019
- Dr. Agura
- Michigan median
- Medicare services
- 1,342vs 6192.2 times
- Part D claims
- 228vs 37840% below
Medians across 291 hematologists and oncologists in Michigan with Dmand AI profiles that report each measure.
Dr. Agura's most billed Medicare procedure codes, 2019
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Agura?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Agura and other hematologists and oncologists in Michigan.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Edward D. Agura's patients have a median age of 60
Across all payers, Dmand AI patient panel data puts Dr. Agura's median patient age at 60, with 34% women.
Dr. Agura's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 60
Patient panel by sex, all payers
- Women34%
- Men66%
Source: Dmand AI Patient Panel Data
Dr. Edward D. Agura wrote 228 Medicare Part D claims in 2019
In 2019, Dr. Agura wrote 228 Medicare Part D claims. They cover 10 drugs, with $981,014 in total drug cost. In 2018, CMS named 447 claims across 20 drugs.
Dr. Agura's most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2018 to 2019
- 2018
- 2019
- Claims for drugs CMS names
- 2018: 4472019: 22849%
Drugs named by CMS: 10 in 2019, 20 in 2018.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Edward D. Agura has 44 publications on record
Dmand AI links 44 papers to Dr. Agura, published from 2004 to 2021. 2013 was the busiest year, with 4. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Graft vs Host Disease. Dr. Agura has published most often in Blood. Dr. Agura's most frequent co-authors are Michael Brian Maris, MD, Veronika Bachanova, MD and Stephen J. Forman, MD.
Dr. Agura's papers by year, 2007 to 2021
Topics Dr. Agura writes about most
- Hematopoietic Stem Cell Transplantation
- Transplantation Conditioning
- Graft vs Host Disease
- Transplantation, Homologous
- Whole-Body Irradiation
- Bone Marrow Transplantation
- Histocompatibility Testing
- Tissue Donors
Dr. Agura's most frequent co-authors
- Michael Brian Maris, MD13 shared papers
- Veronika Bachanova, MD6 shared papers
- Stephen J. Forman, MD5 shared papers
Recent publications by Dr. Agura
See who Dr. Agura researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Agura works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Edward D. Agura has worked on 10 clinical trials
Dmand AI links Dr. Agura to 10 clinical trials, 5 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Leukemia, Myeloid. Medical College of Wisconsin sponsors the most, 2.
Clinical trials with Dr. Agura by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Agura's trials
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Leukemia, Myeloid
- Anemia, Aplastic
- Hodgkin Disease
Investigators on the most trials with Dr. Agura
- Edward D. Ball, MD3 shared trials
- Philip Louis McCarthy, MD3 shared trials
- Tsiporah B. Shore, MD3 shared trials
Recent clinical trials with Dr. Agura
Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma (opens in a new tab)
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (opens in a new tab)
A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma (opens in a new tab)
Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Edward D. Agura received $6,339 in industry payments from 2016 to 2025
CMS Open Payments shows 44 general payments to Dr. Agura from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Seagen Inc. paid the most, $4,057.
General payments to Dr. Agura by program year, 2016 to 2025
General payments to Dr. Agura by kind, 2016 to 2025
- Speaker and faculty fees$3,00047%
- Consulting fees$1,34021%
- Food and beverage$1,01416%
- Travel and lodging$91014%
- Education$751%
Companies that paid Dr. Agura the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Edward D. Agura graduated from New York University School of Medicine
Dr. Agura graduated from New York University School of Medicine in 1982. Dr. Agura is a member of ASCO.
- Medical school
Source: Dmand AI Professional Profile Data
Dr. Edward D. Agura accepts plans from 3 insurance carriers
Dr. Agura is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Delta Dental. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Michigan
- Elevance
- Delta Dental
Plan types Dr. Agura accepts, by number of carriers
- HMO2
- PPO2
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Edward D. Agura's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Edward D. Agura
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Edward D. Agura's NPI number?
Dr. Edward D. Agura's NPI number is 1871531350. It was assigned on June 4, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Edward D. Agura?
Dr. Edward D. Agura is a hematologist and oncologist in Grosse Pointe Woods, Michigan. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Edward D. Agura practice?
Dr. Agura practices at 20870 Mack Ave, Grosse Pointe Woods, MI 48236. Dr. Agura's primary practice is Center for Preventive Medicine in Grosse Pointe Woods, Michigan.
What is Dr. Edward D. Agura's office phone number?
The practice phone on file for Dr. Agura is (313) 885-2334.
What is Dr. Edward D. Agura's medical license number?
Dr. Agura's Texas license number on file is J5681.
Does Dr. Edward D. Agura accept Medicare?
Yes. CMS data shows Dr. Agura billed Medicare for 1,342 services in 2019.
What services does Dr. Edward D. Agura bill to Medicare?
In 2019, Dr. Agura's most billed Medicare services were hospital inpatient care (99233), lab and pathology test (80053) and lab and pathology test (83615).
Where did Dr. Edward D. Agura go to medical school?
Dr. Agura graduated from New York University School of Medicine in 1982.
What drugs does Dr. Edward D. Agura prescribe most?
In 2019 Medicare Part D data, Dr. Agura's most prescribed drugs by claims were Valacyclovir, Pomalyst and Acyclovir.
Has Dr. Edward D. Agura received payments from drug or device companies?
CMS Open Payments shows $6,339 in general payments to Dr. Agura from 15 companies from 2016 to 2025. The largest total came from Seagen Inc.
Show 4 more questionsShow fewer questions
How long has Dr. Edward D. Agura been practicing?
Dr. Agura graduated from medical school in 1982, 44 years ago.
Does Dr. Edward D. Agura do research?
Dmand AI links 44 publications to Dr. Agura, published from 2004 to 2021. Dr. Agura has worked on 10 clinical trials.
Who does Dr. Edward D. Agura publish with?
Dr. Agura's most frequent co-authors are Michael Brian Maris, MD (13 shared papers), Veronika Bachanova, MD (6 shared papers) and Stephen J. Forman, MD (5 shared papers).
What insurance does Dr. Edward D. Agura accept?
Dr. Agura is in network with 3 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Delta Dental. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card